Skip to end of metadata
Go to start of metadata




Name Affiliation
Rob HausamHausam Consulting
Andrea PitkusUniversity of Wisconson
Matt Ellrod
Ralf HerzogRoche
JD NolenChildren's Mercy Hospital
Lorraine ConstableConstable Consulting
Hans BuitendijkCerner
Marti VelezisSonrisa / FDA
David BurgessLabCorp
Molly MalaveyAMA
Nancy SpectorAMA
Dan RutzEpic
Becky GradlAcademy of Nutrition and Dietetics
Freida HallQuest Diagnostics

Chair: Hans Buitendijk

Scribe: Hans Buitendijk


  • Minutes 
    • 2020-09-21-25 
      • Missing administration quarter
      • Links to be completed.  Co-chairs need to check.
    • 2020-10-01 - Motion to accept as published, JD Nolen, Rob Hausam
      • Against: 0; Abstain: 2; In Favor: 10

  • PSS
    • Supplemental Guide for C-CDA Attachments
      • Need to ask why this is going to the Admin SD: scope/need did not change.  Project was already approved by TSC.  Only dates seem to change that can be accommodated by a simple fix and new NIB.  If substantially changing scope would be helpful to clarify that.
    • Presentation on PSS-1664 - Interoperability of Advance Directives (in FHIR)
      • PSS-1664 - Getting issue details... STATUS
      • Suggestion to start with interested party and move to co-sponsor if changes needed. 
      • On the other hand it is not yet clear how/when to use OO resources which would require more discussion and perhaps benefit from co-sponsorship.
      • Other groups to consider are SOA consent project and BPM+ effort.
      • Motion to become co-sponsor with periodic updates and in particular a design review to understand how OO resources are to be used.  Lorraine Constable, Andrea Pitkus.
        • Clarified periodic is to be based on progress and focus and particularly during design and as part of OO calls.
        • Against: 0; Abstain: 1; In Favor: 10
  • Radiology Pathology Concordance Reporting (CAP/ACR )
    • Need for a concordance report.  It appears that this is about guidance on how to communicate about a concordance report process and the resulting report 
    • If the general process is that an imaging report and diagnostic report are effectively "blended" into a third report that combines materials, references, etc. don't we have another DiagnosticReport (+ Composition as needed) to represent that?  What is the need for another IG?
    • Suggestion is that perhaps examples of such a concordance report would be helpful to ensure DiagnosticReport + Composition can handle that output, while the application creating it (with or without user intervention) does what it does based on the reports provided as input.
    • Next step is to finish the DiagnosticReport and Composition discussion/decision on how to use them together, or blend, using concordance reporting as an example to validate completeness and ability to support as well.
    • Explore whether one or more concordance report examples are sufficient to then be included in the resource definitions, or that a separate IG is needed as well.  Andrea has a bone marrow example, and there are others to be considered.
    • JD Nolen to drive OO on FHIR call to resolve this, starting next week.
    • There is another issue to still clarify better when to use an Observation vs. when to use a DiagnosticReport.  That is to be picked up by OO on FHIR as well.

  • Upcoming OO-BR&R Calls
    • Monday, October 12 – 2-3pm ET – Specimen/Sample
    • Monday, October 12 – 3-4pm ET -  Substance/SubstanceDefinition/PacagedProductDefinition
    • Tuesday, October 13 – 4-5pm ET – Observations on manufacturing process, e.g., quality control
    • First two are on the OO Zoom, and the third will use the BR&R Zoom
    • Hans Buitendijk to send reminder.

  • v2 Change Requests - Next Week
  • Project updates - Not discussed
    • Nutrition
      • Met this week (9/30/2020)
      • Reviewed updating DAM scope, aligning with MCC E care plans (PC is sponsoring) 
      • Meeting
        • Every other Wednesday 2-3 ET
      • Project page link: Nutrition
    • Specimen DAM
    • FHIR - OO on FHIR
      • No meeting next week
      • Meeting
        • Every Tuesday 2 - 3 PM ET
      • Project page link: FHIR
      • IHE needs to update Volume IV to reflect CMS vocabulary.
      • Also needs to consider alternative use of ORU to clarify how OBX could be used, plus mapping to FT1.
      • CDSM connection is still proprietary, interest to get CDS Hooks/Standards.
      • Change to the name of the LOINC Code. 
    • CIMI/Concept Modeling - NO UPDATE
      • Co-chair will meet to discuss the future of the group – Lorraine will check what’s up
      • Need to sort out Post-Acute Orders vs. DME (as in NIB).
      • Check with Bob Dieterle.  Needed before publication.
      • Project Page Link: DME Project
    • Healthcare Product: Device/DeviceDefinition/UDI
      • UDI DAM in ballot recon
      • 17 items in discussion 
      • BR&R - meeting October 12th on substance, substance definition, package products definition  
      • Resource Proposal Updates
      • Meeting: Every Monday 3 -4 PM ET
    • V2+  NO UPDATE
      • Still need to look at open tickets and message structure issues (debate continues) 
      • Meetings:
        • Every other Friday, 9-10am ET
      • Project Page Link: V2+
    • V2-to-FHIR 

    • US Realm Lab (eDOS/LOI/LRI) 
      • Frieda updating documents for publication 
    • Product Grid – no update, is not needed this cycle
      • Possible review at WGM  
      • Co-chair meeting to re-group.
      • Need to still review the status of our standards in the product grid:
        • Status definitions - Riki to follow up to see where those are in the grid - here are the ones given to TSC:
          • active, planned use or in use, future maintenance release
            • stable, in use, generate feedback, not active
            • review, not updated in foreseeable future
            • deprecated - deprecated - no further work planned - if not already using, it is not recommended to be implemented